Literature DB >> 15607232

Protection of PC12 cells from hydrogen peroxide-induced injury by EPS2, an exopolysaccharide from a marine filamentous fungus Keissleriella sp. YS4108.

C Sun1, C Y Shan, X D Gao, R X Tan.   

Abstract

A number of studies indicate that free radicals are involved in the neurodegeneration in Parkinson's and Alzheimer's diseases. EPS2, an exopolysaccharide with a mean molecular weight of 1.3 x 10(5) Da, was isolated by ion-exchange and sizing chromatography from the culture of Keissleriella sp. YS4108, a marine filamentous fungus. Compositionally, it is composed of galactose, glucose, rhamnose, mannose and glucuronic acid in an approximate proportion of 50:8:1:1:0.4. The protective effects of EPS2 on peroxide hydrogen (H2O2)-induced cell lesion, level of lipid peroxidation, antioxidant enzyme activities were investigated in the rat pheochromocytoma line PC12 cells. Following a 1-h exposure of the cells to H2O2, a significant reduction in cell survival and activities of glutathione peroxidase (GSH-Px) and catalase (CAT), as well as increased levels in malondialdehyde (MDA) production and lactate dehydrogenase (LDH) release were observed. However, preincubation of the cells with EPS2 prior to H2O2 exposure elevated the cell survival and GSH-Px and CAT activities, and decreased the level of MDA and LDH activity in a dose-dependent manner. In conclusion, EPS2 possesses pronounced protective effects against H2O2-induced cell toxicity. The finding is of a higher value in searching for new therapeutic agent for treating oxidative damage-derived neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15607232     DOI: 10.1016/j.jbiotec.2004.08.011

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  8 in total

Review 1.  Marine polysaccharides in pharmaceutical applications: an overview.

Authors:  Paola Laurienzo
Journal:  Mar Drugs       Date:  2010-09-02       Impact factor: 5.118

2.  Culture Conditions for Production of Biomass, Adenosine, and Cordycepin from Cordyceps sinensis CS1197: Optimization by Desirability Function Method.

Authors:  Shashidhar M Ghatnur; Giridhar Parvatam; Manohar Balaraman
Journal:  Pharmacogn Mag       Date:  2015-10       Impact factor: 1.085

3.  Osirisynes G-I, New Long-Chain Highly Oxygenated Polyacetylenes from the Mayotte Marine Sponge Haliclona sp.

Authors:  Pierre-Eric Campos; Gaëtan Herbette; Christophe Chendo; Patricia Clerc; Florent Tintillier; Nicole J de Voogd; Eleni-Dimitra Papanagnou; Ioannis P Trougakos; Moran Jerabek; Jérôme Bignon; Géraldine Le Goff; Jamal Ouazzani; Anne Gauvin-Bialecki
Journal:  Mar Drugs       Date:  2020-07-03       Impact factor: 5.118

Review 4.  Bioactive Carbohydrate Polymers-Between Myth and Reality.

Authors:  Maroua Drira; Faiez Hentati; Olga Babich; Stanislas Sukhikh; Viktoria Larina; Sana Sharifian; Ahmad Homai; Imen Fendri; Marco F L Lemos; Carina Félix; Rafael Félix; Slim Abdelkafi; Philippe Michaud
Journal:  Molecules       Date:  2021-11-23       Impact factor: 4.411

Review 5.  Strategies to Maximize the Potential of Marine Biomaterials as a Platform for Cell Therapy.

Authors:  Hyeongmin Kim; Jaehwi Lee
Journal:  Mar Drugs       Date:  2016-01-26       Impact factor: 5.118

6.  Characterization of lactic acid bacteria derived exopolysaccharides for use as a defined neuroprotective agent against amyloid beta1-42-induced apoptosis in SH-SY5Y cells.

Authors:  Seda Sirin; Belma Aslim
Journal:  Sci Rep       Date:  2020-05-15       Impact factor: 4.379

7.  Promotion of Wound Healing and Prevention of Frostbite Injury in Rat Skin by Exopolysaccharide from the Arctic Marine Bacterium Polaribacter sp. SM1127.

Authors:  Mei-Ling Sun; Fang Zhao; Xiu-Lan Chen; Xi-Ying Zhang; Yu-Zhong Zhang; Xiao-Yan Song; Cai-Yun Sun; Jie Yang
Journal:  Mar Drugs       Date:  2020-01-11       Impact factor: 5.118

Review 8.  Bioactivities, isolation and purification methods of polysaccharides from natural products: A review.

Authors:  Lei Shi
Journal:  Int J Biol Macromol       Date:  2016-07-01       Impact factor: 6.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.